Literature DB >> 31680603

Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration.

Anika L Dzierlenga1, Veronica G Robinson1, Suramya Waidyanatha1, Michael J DeVito1, Max A Eifrid2, Seth T Gibbs2, Courtney A Granville2, Chad R Blystone1.   

Abstract

Poly- and perfluorinated alkyl substances (PFAS) are environmentally persistent chemicals associated with many adverse health outcomes. The National Toxicology Program evaluated the toxicokinetics (TK) of several PFAS to provide context for toxicologic findings.Plasma TK parameters and tissue (liver, kidney, brain) concentrations are reported for perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) or perfluorodecanoic acid (PFDA) after single-dose administration in male and female Hsd:Sprague-Dawley® (SD) rats.Generally, longer Tmax and elimination half-lives, and slower clearance f, were correlated with longer chain length. Male rats administered PFOA had a prolonged half-life compared to females (215 h vs. 2.75), while females had faster clearance and smaller plasma area under the curve (AUC). Females administered PFHxA had a shorter half-life (2 h vs. 9) than males and faster clearance with a smaller plasma AUC, although this was less pronounced than PFOA. There was no sex difference in PFDA half-life. Female rats administered PFDA had a higher plasma AUC/dose than males, and a slower clearance. PFDA had the highest levels in the liver of the PFAS evaluated.Profiling the toxicokinetics of these PFAS allows for comparison among subclasses, and more direct translation of rodent toxicity to human populations.

Entities:  

Keywords:  PFDA; PFHxA; PFOA; Perfluorinated chemicals; toxicokinetics

Mesh:

Substances:

Year:  2019        PMID: 31680603     DOI: 10.1080/00498254.2019.1683776

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment.

Authors:  Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Virginia A Rauh; Morgan Robinson; Kurunthachalam Kannan; Leonardo Trasande; Julie Herbstman
Journal:  Environ Pollut       Date:  2020-03-26       Impact factor: 8.071

2.  In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.

Authors:  Nicola Evans; Justin M Conley; Mary Cardon; Phillip Hartig; Elizabeth Medlock-Kakaley; L Earl Gray
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-22       Impact factor: 4.460

3.  The toxicity of perfluorodecanoic acid is mainly manifested as a deflected immune function.

Authors:  Keming Li; Qian Zhao; Ziyan Fan; Shouyin Jia; Qing Liu; Fengyan Liu; Shili Liu
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

4.  Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring.

Authors:  Wieneke Bil; Marco J Zeilmaker; Bas G H Bokkers
Journal:  Environ Health Perspect       Date:  2022-07-26       Impact factor: 11.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.